{"abstract":"This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), is thinking about giving a co-exclusive license in Africa, in the field of use of veterinary vaccines, to practice the inventions listed in the patent applications referred to below to Deltamune Ltd., having a place of business in Centurion, South Africa. The patent rights in these inventions have been assigned to the government of the United States of America. The patent applications(s) to be licensed are:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Disease Control and Prevention","name":"Centers for Disease Control and Prevention","id":44,"url":"https://www.federalregister.gov/agencies/centers-for-disease-control-and-prevention","json_url":"https://www.federalregister.gov/api/v1/agencies/44","parent_id":221,"slug":"centers-for-disease-control-and-prevention"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/11/16/2012-27896.html","cfr_references":[],"citation":"77 FR 68783","comment_url":null,"comments_close_on":"2012-12-17","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by CDC on or before December 17, 2012 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-27896","effective_on":null,"end_page":68783,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/11/16/2012-27896.xml","html_url":"https://www.federalregister.gov/documents/2012/11/16/2012-27896/prospective-grant-of-co-exclusive-license-veterinary-vaccines-for-rift-valley-fever-virus","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-27896?publication_date=2012-11-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-11-16/2012-27896/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":37,"last_updated":"2026-09-20 22:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-11-16/pdf/2012-27896.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-27896.pdf?1352987539","publication_date":"2012-11-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/11/16/2012-27896.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2012-12-06T08:05:31Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":68783,"subtype":null,"title":"Prospective Grant of Co-Exclusive License: Veterinary Vaccines for Rift Valley Fever Virus","toc_doc":"Veterinary Vaccines for Rift Valley Fever Virus","toc_subject":"Prospective Grant of Co-Exclusive Licenses:","topics":[],"type":"Notice","volume":77}